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a b s t r a c t
Lactic acidosis (LA) is characterized by accumulation of lactate in the body, and itmaydetrimentally affect
homeostasis. Perioperative LA is rarely seen, here we presented 2 cases of patients suffered with tempo-
rary hyperlactataemia during partial hepatectomy, intended to emphasize that prolonged hypovolemia
condition caused by controlled low central venous pressure, and overused hepatic vascular occlusionccepted 18 September 2014





technique during parenchymal resection of hepatic surgery may seriously impact on the internal envi-
ronment of patients. And we also discussed how to well manage long-time hepatectomy to prevent LA
from occurring and to treat it appropriately.
© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).. Introduction
Lactic acidosis (LA) is deﬁned as metabolic acidosis caused
y accumulation of lactate in the body, and is characterized by
yperlactataemia with a plasma lactate concentration of above
mmol/L.1 It is mostly found in patients with shock, sepsis,
iver disease and respiratory failure, and is of low survival rate.2
owever, it is not known how common it is for temporary hyper-
actataemia to occur during liver resection. Here we presented 2
ases of temporaryhyperlactataemiawhichoccurredduringpartial
epatectomy, and considered that prolonged hypovolemia caused
y controlled low central venous pressure (CLCVP), and overused
epatic vascular occlusion (HVO) during parenchymal transection
ay seriously impact the internal environment of patients. How-
ver, this complication may fully recover within a short time with
o serious consequence if properly treated.
. Case presentation
.1. Case 1A 64-year-old Chinese woman diagnosed with hilar cholangio-
arcinoma, but with no history of cardiovascular or respiratory
isease, diabetes mellitus, blood transfusion or allergy, was
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http://creativecommons.org/licenses/by-nc-nd/3.0/).scheduled for liver segments I, V, VI, VII and VIII resection. Her
laboratory examinations were unremarkable.
Rapid sequence introduction (RSI) followed by intratracheal
intubation were achieved. Anesthesia was maintained by continu-
ous propofol infusion and sevoﬂurane inhalation. A central venous
line via the right internal jugular vein and a radial arterial can-
nula were then placed for measurement of central venous pressure
(CVP) and arterial blood pressure (ABP), respectively at the start
of the operation. 21/2 h into the operation, the patient had totally
received colloid 1750ml, Inverl Sugar Injection (ISI) 100ml, and the
ABP was 80–90/40–50mmHg, CVP 3 cm H2O. Then colloid 250ml
and ISI 400ml were dripped continuously at a low rate. 31/2 h
into the operation, the 1st blood gas analysis revealed pH 7.27, lac
2mmol/L, BE −8.8mmol/L, Glu 12.2mmol/L (Table 1).
5 h into the operation, because of rapid bleeding from the oper-
atingﬁeld (about 50mlbleeding in5min), the surgeons requested a
CLCVP. The CVP was lowered to 2 cm H2O by restricting ﬂuid trans-
fusion. As the ABP was 80–85/45–50mmHg, epinephrine infusion
in 0.1mg/h was used to maintain the mean arterial pressure (MAP)
at 50–60mmHg. 61/3 h into the operation, parenchymal transec-
tion started under CLCVP. 35min later, the 2nd blood gas analysis
revealed pH7.29, lac 5.4mmol/L, BE−8.1mmol/L, Glu 17.1mmol/L.
5%NaCO3 250mlwere immediately administered for acidosis ther-
apy. During this period, complete HVO of less than 15min eachwas
implemented twice. 111/2 h into the operation, parenchymal tran-
section ﬁnished. The total blood loss was 1700ml. Because of the
unstable circulation, epinephrine 0.1–0.4mg/h was continuously
infused to maintain the ABP at 80–85/45–50mmHg. Meanwhile,
the 3rd blood gas analysis revealed pH 7.01, Lac 15mmol/L, BE
−20.3mmol/L, and Glu 21.3mmol/L, another 150ml of 5% NaCO3
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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Table 1
Blood gas analysis of the 1st patient.
Time pH pCO2 (mmHg) pO2 (mmHg) K+ (mmol/L) Ca2+ (mmol/L) Glu (mmol/L) Lac (mmol/L) Hct (%) Hb (g/dL) HCO3− (mmol/L) BE (mmol/L)
19:06 7.27 38 543 5.2 1.08 12.2 2 27 8.4 17.4 −8.8
22:25 7.29 37 558 3 1.03 17.1 5.4 27 8.4 17.8 −8.1
0:24 7.01 40 520 3.5 0.9 21.3 15 26 8.1 10.1 −20.3
1:32 7.06 39 515 3.4 0.93 19.5 >15 26 8.1 11 −18










































B3:42 7.33 44 475 3.3 0.81
4:20 7.2 30 207 3.2 1.01
8:57 7.5 40 142 4.1 1.05
ere administered. Hypertonic Sodium Chloride Hydroxyethyl
tarch 40 Injection 400ml, concentrated red blood cells (CRBC) 4u
nd fresh frozen plasma (FFP) 450ml were given for ﬂuid resusci-
ation. The ABP was elevated to 105–115/70–80mmHg, but blood
as analysis revealed lactate concentration still remained above
5mmol/L (Table 1). At the end of the operation, the patient was
ept anesthetized and transferred to the intensive care unit (ICU)
or postoperative management without removal of the tracheal
ube.
Follow-up in the next day, the patient was conscious with no
emarkable complications and was extubated in the afternoon. He
as then transferred to the generalwardwith an uneventful recov-
ry. The last blood sample taken in the morning revealed pH 7.50,
ac 10.1mmol/L, BE 7.4mmol/L, and Glu 14.7mmol/L.
.2. Case 2
A 57-year-old Chinese man with alcoholic liver disease and a
arge right liver hepatocellular carcinoma was scheduled for liver
egments VI and VII resection. There was no history of cardio-
ascular or respiratory disease, diabetes mellitus or allergy. His
aboratory examinations were unremarkable.
The patient’s preoperative ABP was 154/73mmHg. General
nesthesia was induced by RSI, and was maintained with sevoﬂu-
ane, propofol and dexmedetomidine. Folley catheter insertion,
entral venous catheterization via the right internal jugular vein
nd radial arterial cannulation were then inserted to measure the
rinevolume, CVPandABP.At the start of theoperation, the systolic
lood pressure (SBP) and CVP were maintained at 120–130mmHg
nd 6cm H2O, respectively, by crystalloid/colloid transfusion and
nesthetics. 30min into the operation, the 1st blood gas anal-
sis revealed pH 7.29, Lac 1.7mmol/L, BE −7.3mmol/L and Glu
.2mmol/L (Table 2).
12/3 h into the operation, hepatic parenchymal transection
tarted and the recorded urine volume was 450ml. To facilitate
he surgical procedure, the CVP was maintained at 2–4cmH2O, and
BP>90mmHg. 4h into the operation, parenchymal transection
asﬁnished (tumorsize10 cm×10 cm×5 cm).During the transec-
ion, right-HVOwas implemented for 8 times (mean occlusion time
3.4min, mean interval time 6.7min). The total colloid transfusion
olume was 750ml, Ringer’s solution 500ml, Plasmalyte-A 500ml,
lood loss was 600ml and urine 250ml. The 2nd blood gas analy-
is at this time revealed pH 7.19, Lac 7.2mmol/L, BE −11.4mmol/L,
able 2
lood gas analysis of the 2nd patient.
Time pH pCO2 (mmHg) pO2 (mmHg) K+ (mmol/L) Ca2+ (mmol/L) Glu (m
14:17 7.29 39 208 3.1 1.33 7.2
18:04 7.19 43 256 3.8 1.2 8
19:09 7.21 49 270 3.4 1.16 7.7
20:21 7.24 54 247 3.2 0.99 7.9
21:03 7.27 47 246 3.1 1.08 7.5
21:27 7.19 59 126 3.1 1.04 7.4
06:06 7.38 45 82 3.3 1.01 14.9>15 31 9.6 23.2 −2.7
>15 37 13 11.7 −15
10.1 36 12.6 31.2 7.4
Glu 8mmol/L. 5% NaCO3 100ml were immediately administered,
and massive transfusion of Plasmalyte-A combined with diuresis
by furosemide for lactate discharge were initiated. 1h later, blood
gas analysis revealed pH 7.21, Lac 9.1mmol/L, BE −8.2mmol/L, Glu
7.7mmol/L. 5% NaCO3 150ml were given and Plasmalyte-A trans-
fusion with diuresis were continued.
The patient’s vital signs were stable till the operation was ﬁn-
ished . He was extubated 11/2 h later and transferred into the ICU.
During LA therapy, the patient had totally received colloid 500ml,
Plasmalyte-A 4500ml and urinated 4800ml, the blood lactate level
raised to 11.4mmol/L and then declined (Table 2).
Follow-up in the next day, the patient had been sent back to
the general ward and was conscious with stable vital signs. Blood
gas analysis in the morning revealed pH 7.38, BE 0.9mmol/L, Glu
7.7mmol/L, but lactate concentration was unknown because a dif-
ferent blood gas analyzer was used. Anion gap (AG) was calculated
as 12mmol/L (normal value 8–16mmol/L). The patient also had an
uneventful recovery and discharged two weeks later.
3. Discussion
Lactate is a byproduct of glycolysis from pyruvate metabolism
in anaerobic conditions. It can be produced in any kind of tis-
sue and is rapidly metabolized by the liver and kidneys. Hence,
the blood lactate level is usually between 0.5 and 1.0mmol/L.3
LA is a kind of metabolic acidosis when lactate accumulates in
the body. It is deﬁned to happen with pH<7.35, Lac >5mmol/L,
HCO3− <15mmol/L and increased AG. The clinical manifestations
of LA are hyperventilation, tachycardia, hypotension, and circula-
tory instability,1 mostly found in patients with shock, sepsis, liver
disease, and respiratory failure, and is refractory to normal acido-
sis therapy with a mortality rate of nearly 80%.4 It happens also in
diabetic patients who are alcoholic or treated with metformin and
in patients who are lack of vitamin B1 or with propofol infusion
syndrome (PRIS).4–9
Kelliher and Fawcett10 reported a case of LA in a diabetic patient
treated with metformin who underwent hepatic resection, but
the patient’s ABP or CVP during the surgical procedure were not
mentioned. The author emphasized the side-effect of metformin
which inhibitedhepatic and renal gluconeogenesis, resulting in lac-
tate accumulation, and recommended to stop the drug 48h before
surgery. However, Cox and his colleagues11 studied the prevalence
of LA in diabetic ketoacidosis (DKA). They discovered that lactate
mol/L) Lac (mmol/L) Hct (%) Hb (g/dL) HCO3− (mmol/L) BE (mmol/L)
1.7 39 12.1 18.8 −7.3
7.2 40 12.4 16.4 −11.4
9.1 37 11.5 19.6 −8.2
10.8 41 12.7 23.1 −4.8
11.4 42 13 21.6 −5.3
11.1 43 13.3 22.5 −5.7
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nd glucose levels in DKA patients were correlated positively
r=0.34; P=0.004), and considered the causes of lactate accumu-
ation were due to ischemia and hypoxia of tissues as a result
f dehydration induced hypoperfusion and stress induced cate-
holamine release. Coincidently, patients in Kelliher’s case and our
st case both presented with a high glucose level (15mmol/L and
2.2–21.3mmol/L, respectively). Therefore, perioperative hyper-
lycemia is an important inducing factor of LA.
Although our 2nd patient did not present with a dramatically
levated glucose level (7.2–8mmol/L), LA still occurred. Obviously,
here are many common features between the two cases, such as
rolonged periods of hypotension, CLCVP, HVO and propofol infu-
ion.
PRIS induced LA is not common, but is potentially lethal, so ade-
uate attention should be given. This disorder is usually triggered
y propofol infusion faster than 5mg/kg/h for more than 48h. It is
haracterized by LA, heart failure and a disturbance in mitochon-
rial long chain fatty acid oxidation inducedmultiorgan failure and
habdomyolysis.6–9 Mijzen et al.12 suggested that under normal
onditions, reversal of T-waves on the electrocarodiogram (ECG)
ay be an early warning sign of PRIS. Despite there is no evidence
hether ourpatients presentedwithPRIS, anesthesiologists should
ay attention to the emulsive property of propofol.
Innormal conditions, the liver accounts formore than50%of lac-
ate clearance,3 therefore, lactate metabolism will be disturbed in
onditions of hepatic dysfunction or HVO. A study has shown that
he blood lactate level was signiﬁcantly elevated after occlusion
f the liver hilus in hepatectomy,13 thus, if the process of hepatic
arenchyma transection is prolonged, and HVO is performed fre-
uently or reperfusion period is short, lactate will undoubtedly
ccumulate. This indicated that extra lactate production and its
iminished clearance should happen with HVO. In our cases, the
st patient received complete HVO twice and hepatic parenchymal
ransection lasted 2h40min, while in the other patient, right HVO
as for8 times, and transectionwas for2h35min.Despite thedura-
ion of major surgical procedure in Kelliher’s case was not given,
he total operative time was 6.5h.10 Consequently, we inferred
hat profound LA may be induced by prolonged period of hepatic
arenchymal transection andwith prolonged total HVOandCLCVP.
Many studies showed that CLCVP in partial hepatectomy does
ot impact on hepatic or renal function.14,15 However, the SBP
r MAP should be appropriately kept to ensure adequate organs
lood perfusion. When CLCVP leads to hypovolemia, and induces
uctuant hemodynamics, maintaining a targeted blood pres-
ure becomes thorny. Our 1st patient suffered with hypovolemia
nd subsequent refractory hypotension because of CLCVP, which
ndoubtedly diminished organic perfusion and promoted lactate
roduction. In addition, the use of vasoconstrictor exacerbated the
nfavorable condition, caused further tissue ischemia and aggra-
ated LA.
Sodium acetate infusion as a therapeutic measure for acidosis
as been validated.16,17 In early 1982, Hamat and his colleagues18
onﬁrmed the effective use of sodiumacetate on LA froman in vitro
tudy, and they considered themechanism is due to sodiumacetate
articipating in the tricarboxylic acid (TCA) cycle for adenosine
riphosphate (ATP) synthesis, and thus glycolysis and lactate accu-
ulation decreased. Additionally, this unique metabolic pathway
as no impact on liver or renal function, and it is recommended
or treating patients with stable hemodynamics. This was the main
pproach we took to treat our 2nd patient. For those with impaired
enal function, peritoneal dialysis and hemodialysis with sodium
cetate should be considered.3When the pH falls below 7.20, severely adverse hemody-
amic changes may occur, and sodium bicarbonate should be
dministered,1 however, the validity of this treatment is still
n question. Kim and his colleagues19 reported a retrospectivePEN ACCESS
ery Case Reports 6 (2015) 285–288 287
analysis on 103 LA patients, and discovered that patients treated
with sodium bicarbonate were associated with a higher mortal-
ity when compared to those without, and considered that NaCO3
merely corrects the pH value, but not inhibits lactate production
or promotes its elimination. Besides, acidosis reduces the activ-
ity of phosphofructokinase, therefore inhibits lactate production.
If NaCO3 is used to correct acidosis, lactate may accumulate by
canceling the beneﬁt. Arieff’s20 animal experiment also showed
that NaCO3 resulted in a decline of liver and erythrocyte pHi
(intracellularpH), increasedgut lactateproduction, diminishedcar-
diac output and hepatic portal vein blood ﬂow. Therefore, NaCO3
administration in treating LA should be cautious. This conclusion
corresponded to the phenomenon in our 2 cases, that the pH value
was corrected while the lactate level was still elevated. Kim’s study
also showed that the highest mortality rate of LA was in patients
with sepsis, and then hepatic failure, cardiogenic shock, etc.19 The
favorable prognosis of our 2 patients indicated that temporary
hyperlactataemia occurring during partial hepatectomy is not as
fatal as LA which is induced by other diseases.2,4,19 Our explana-
tion is as follows: (1) Both our patients had no underlying diseases
that may lead to lactate accumulation, and their liver function
were relatively normal preoperatively. (2) Intraoperative produc-
tion of lactate could cease quickly after reperfusion of the liverwith
improvement in tissue perfusion or oxygen supply by rehydration
and blood transfusion. (3) Excess lactate could be cleared quickly
by the liver and kidneys that function well. (4) These results are
comparable with those of Cox’s,11 they found that a DKA patient
with LA was not associated with a worse prognosis. Thus, we won-
der if a single reading of hyperlactataemia is a valuable predictor
of patients’ outcome.
Dichloroacetate (DCA) is a speciﬁc agent to treat LA, it activates
pyruvatedehydrogenase, increasespyruvateoxidationand reduces
lactate production. It also promotes regional lactate transport,
raises plasma bicarbonate concentration and pH value, reduces the
fatality rate of LA patients; although it raises plasma ketone-body
concentration, appreciable drug toxicity is rarely seen in short-
term administration of DCA.1,21,22 Regrettably, we had no DCA at
that time. Other drugs for treating LA include insulin, vitamin B1,
methylene blue, etc. However, they are of limited effects.1
4. Conclusions
Perioperative lactic acidosis is rarely seen. The purpose we
reported these 2 cases was to emphasize the importance of peri-
operative management of hepatic surgery. LA is hardly perceived
simply by monitoring the patient’s vital signs. However, its fatality
rate is high, and anesthesiologists should be on the alert. The CLCVP
technique iswidely performed during hepatic resection surgery for
its various advantages, but the operative times included in most
researches are relatively short, hence, the duration of CLCVP and
HVO are short correspondingly. Thus, if the operation time, espe-
cially parenchymal transection is prolonged, a beneﬁt-risk balance
of CLCVP should be further studied, because a prolonged hypo-
volemia period is harmful to patients. Blood gas analysis is the
main approach to perceive LA during operation, but we rarely take
blood samples for its detection. Delayed diagnosis and therapy
may lead to unfavourable outcomes. Moreover, LA is refractory
to normal therapeutic management on metabolic acidosis, sodium
bicarbonate administration should be reconsidered when the pH
value declines signiﬁcantly, or adverse effects appear.
As we summarized, real-time blood gas analysis should be
recommended inprolongedhepatic surgery.When lactate accumu-
lates, the appropriate procedures should include stopping propofol
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cetate solution (such as Plasmalyte-A) combinedwithdiuretics for
educing lactate production and promoting its elimination. Also,
he glucose level should be well controlled perioperatively. The
idneys still account for signiﬁcant lactate elimination, hence, we
ecommend to mainly use sodium acetate solution for ﬂuid man-
gement and combine it with proper use of diuretics for patients
ndergoing prolonged hepatic surgery as a prophylacsis against LA.
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